Page 25 - View More News Today

As we step into the year's last quarter, it is worth noting that the FDA has already granted approval to 40 novel drugs in 2023, a significant increase compared to the 26 novel drugs approved during the same period last year.

Below are the earnings highlights for Conagra Brands Inc. (CAG): Earnings: $319.7 million in Q1 vs. -$77.5 million in the same period last year. EPS: $0.67 in Q1 vs.

As we step into the year's last quarter, it is worth noting that the FDA has already granted approval to 40 novel drugs in 2023, a significant increase compared to the 26 novel drugs approved during the same period last year.

Acuity Brands, Inc. (AYI) shares are gaining more than 3 percent on Wednesday morning trade after the company reported a lower fourth-quarter profit, however beat estimates.

Below are the earnings highlights for AngioDynamics Inc. (ANGO): Earnings: $45.884 million in Q1 vs. -$13.004 million in the same period last year. EPS: $1.

Acuity Brands, Inc. (AYI) shares are gaining more than 3 percent on Wednesday morning trade after the company reported a lower fourth-quarter profit, however beat estimates.

Danaher Corp. (DHR) shares are sliding more than 4 percent on Monday morning trade, continuing a bearish trend since the company announced the completion of spin-off of Veralto Corp.

Danaher Corp. (DHR) shares are sliding more than 4 percent on Monday morning trade, continuing a bearish trend since the company announced the completion of spin-off of Veralto Corp.

Relmada Therapeutics, Inc. (RLMD) is down over 30% in Friday's pre-market trading. Here is the list of the other big movers..

Shares of browser developer Opera Limited (OPRA) are falling more than 9% Friday morning after the company priced its secondary offering of about 6.88 million ADSs at $12.